Remdesivir (Veklury) for COVID-19

Med Lett Drugs Ther. 2020 Nov 30;62(1612):186-188.
No abstract available

Keywords: COVID-19; Veklury; adverse effects; coronavirus; dosage; drug interactions; efficacy; hydroxychloroquine; interferon beta; lactation; lopinavir/ritonavir; pregnancy; remdesivir; safety.

MeSH terms

  • Adenosine Monophosphate / administration & dosage
  • Adenosine Monophosphate / adverse effects
  • Adenosine Monophosphate / analogs & derivatives*
  • Adenosine Monophosphate / therapeutic use
  • Adult
  • Alanine / administration & dosage
  • Alanine / adverse effects
  • Alanine / analogs & derivatives*
  • Alanine / therapeutic use
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • COVID-19 Drug Treatment*
  • Clinical Trials as Topic
  • Drug Interactions
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Randomized Controlled Trials as Topic

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine